18 months after the global launch of the patent-pending technology and delivery form CONCORDIX™, Ayanda is now presenting a new product; Multivitamins with Omega 3
Ayanda has written a statement showcasing its focus and dedication to providing high quality Omega 3 capsules
Per Benjaminsen, CEO of PROBIO, is from September 5th, 2011 appointed as the new CEO for Ayanda. This move will align the ProBio’s and Ayanda’s business areas into one common organization and thereby achieve a more efficient and integrated organization.
The new name of the operation is Etnovia Oy.
The sale is a following the step in a focused strategy
for Ayanda where SoftGels and ConCordix will be our main strategic
focus moving forward.
Among those individuals who use dietary supplements, fish oil has surpassed multivitamins in popularity.
Study suggests an increased bioavailability by more than 40 percent of omega-3 rich fish oils EPA and DHA by using Ayanda's proprietary technology; ConCordix
Stein Ulve was interviewed by Dr Kevin Robinson; Chief Editor at Nutraceutical Business & Technology
The CONCORDIX™ technology will be marketed under Nycomed’s brand name Nycoplus SmartKidz
CONCORDIX™ will be available in the North American healthcare professional market
Ayanda is the first in the world to use Optical Inspection System in the pharmaceutical industry.